Outcomes at 3 years posttransplant in imlifidase‐desensitized kidney transplant patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes at 3 years posttransplant in imlifidase‐desensitized kidney transplant patients

Published:2021-07-19 Issue:12 Volume:21 Page:3907-3918
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Kjellman Christian¹,Maldonado Angela Q.¹^ORCID,Sjöholm Kristoffer¹,Lonze Bonnie E.²^ORCID,Montgomery Robert A.²,Runström Anna¹,Lorant Tomas³,Desai Niraj M.⁴,Legendre Christophe⁵,Lundgren Torbjörn⁶,Zur Mühlen Bengt³,Vo Ashley A.⁷^ORCID,Olsson Håkan¹,Jordan Stanley C.⁷^ORCID

Affiliation:

1. Hansa Biopharma AB Lund Sweden

2. NYU Langone Transplant Institute New York New York USA

3. Department of Surgical Sciences Uppsala University Uppsala Sweden

4. Johns Hopkins University Baltimore Maryland USA

5. Hôpital Necker & Paris Descartes University Paris France

6. Department of Transplantation Surgery Karolinska Institutet Stockholm Sweden

7. Cedars‐Sinai Medical Center Comprehensive Transplant Center Los Angeles California USA

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16754

Reference26 articles.

1. Desensitization in the Era of Precision Medicine: Moving From the Bench to Bedside

2. Posttransplant Outcomes for cPRA-100% Recipients Under the New Kidney Allocation System

3. Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization?

4. Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab

5. A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing immunosuppression in liver transplantation: A narrative review;Hepatobiliary & Pancreatic Diseases International;2024-10

2. Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series;Transplantation Direct;2024-08-29

3. Research Highlights;Transplantation;2024-08-21

4. Antibody-Mediated Rejection in Lung Transplantation: Diagnosis and Therapeutic Armamentarium in a 21st Century Perspective;Transplant International;2024-08-07

5. Open-Label Phase 1/2 Study of Daratumumab-Based Desensitization Before Kidney Transplantation;Kidney International Reports;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3